Join to View Full Profile
University of Hawaii Cancer Center, 701 Ilalo StreetHonolulu, HI 96813
Phone+1 808-564-3999
Fax+1 808-586-5857
Dr. Cho is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (Irvine)Fellowship, Hematology and Medical Oncology, 1987 - 1989- University of California (Irvine)Residency, Internal Medicine, 1977 - 1978
- University of California (Irvine)Internship, Internal Medicine, 1976 - 1977
University of Hawaii, John A. Burns School of MedicineClass of 1976
Certifications & Licensure
HI State Medical License 1979 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012-2013
Clinical Trials
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Start of enrollment: 2005 Nov 01
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
- Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer Start of enrollment: 2008 Oct 13
- Join now to see all
Publications & Presentations
PubMed
- 40 citationsEffects of a Home-based Exercise Program on Anxiety and Mood Disturbances in Older Adults with Cancer Receiving Chemotherapy.Kah Poh Loh, Ian R. Kleckner, Po-Ju Lin, Supriya G. Mohile, Beverly Canin
Journal of the American Geriatrics Society. 2019-05-01 - 10 citationsErratum: A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreat...Bert H. O'Neil, Aaron Scott, W. W. Ma, Steven J. Cohen, Dara L. Aisner
Annals of Oncology. 2016-06-18 - 20 citationsA phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metast...Bert H. O'Neil, A. J. Scott, W. W. Ma, Steven J. Cohen, Lawrence Leichman
Annals of Oncology. 2015-12-01
Press Mentions
Hawaiian Oncologists Surf Lower Pay, Fewer ResourcesMarch 8th, 2016
Professional Memberships
- Member
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
